Your trusted destination for CME, CPD & Medical Education across the Middle East.
The International Conference on Sustainable Advances in Ophthalmology (ICSAIO-26) is a premier hybrid event for global experts to discuss groundbreaking research, technological advancements, and sustainable practices in eye care.
Hosted by Science Leagues, the International Conference on Sustainable Advances in Ophthalmology (ICSAIO-26) is a prestigious global event designed to unite scholars, educators, and researchers. This hybrid conference serves as a vital platform to present cutting-edge research, explore technological advancements, and exchange innovative ideas in ophthalmology. By fostering an environment of collaboration, it aims to facilitate global dialogue, inspire new perspectives, and drive academic excellence with a special focus on sustainability and alignment with the UN's Sustainable Development Goals.
Exploring the latest in OCT, AI-driven analysis, and other novel imaging modalities for early and accurate diagnosis of ocular diseases.
Discussion on the role of genetic markers and molecular biomarkers for predicting disease onset, progression, and treatment response.
Assessing the impact and implementation of remote diagnostic tools and virtual consultations in expanding access to eye care.
Strategies and innovations for reducing the environmental footprint of high-volume procedures like cataract surgery.
Advancements in minimally invasive approaches for glaucoma (MIGS), retinal, and corneal surgery to improve patient outcomes and efficiency.
Implementing protocols for waste management, resource conservation, and the use of sustainable surgical materials.
Updates on the latest developments in gene therapy and stem cell treatments for inherited and acquired retinal diseases.
Examining new methods for delivering therapeutics to the posterior segment of the eye for conditions like AMD and diabetic retinopathy.
Deepening the understanding of the molecular and cellular mechanisms underlying common retinal disorders.
Review of emerging medications and therapeutic targets for lowering intraocular pressure and managing glaucoma.
Investigating novel approaches to protect the optic nerve and retinal ganglion cells from glaucomatous damage.
Utilizing advanced technology and AI for tracking disease progression and personalizing treatment plans.
Exploring contemporary therapeutic strategies to maximize residual vision and improve quality of life for patients.
Showcasing the latest in low vision aids, from electronic magnifiers to smart glasses and mobile applications.
Best practices for incorporating comprehensive vision rehabilitation services into standard ophthalmology practice.
Secure your seat and earn full credit eligibility with encrypted checkout.
Secure payment processing & PCI-aligned flow
